US Hemodynamic Monitoring System Market to 2027 - Country Analysis and Forecasts by Type (Noninvasive Hemodynamic Monitoring System, Minimally Invasive Hemodynamic Monitoring System, Invasive Hemodynamic Monitoring System); Product (Monitors, Disposables); End User (Hospitals, Cath Labs, Home Care, Ambulatory Care Centers)
US hemodynamic monitoring system market, is anticipated to reach US$ 486.39 Mn in 2027 from US$ 292.28 Mn in 2019. The market is projected to grow with a CAGR of 6.7% from 2020-2027.
The growth of US hemodynamic monitoring system is estimated due to the factors such as increasing product developments and approvals, rising cardiovascular disease prevalence, and growing geriatric population. On the other hand, the market is projected to experience slow growth due to risks associated with invasive hemodynamic monitoring systems.
Advancements in medical technology and innovations, as well as increase in R&D spending by manufacturers, have resulted in the launch of various medical devices, including hemodynamic monitoring systems. At present, the hemodynamic monitoring systems are used to guide physicians to design the therapies or treatments at the time of circulatory instability for the patients living with cardiovascular diseases.
In the US, various players are operating in the hemodynamic monitoring system market; they are involved in the product development activities. For instance, in February 2018, Getinge AB has received Section 510(k) clearance from FDA for its PulsioFlex Monitoring System and PiCCO Module. It is a modular platform integrated with intelligent visualization for advanced hemodynamic patient monitoring. The PulsioFlex Monitoring System is ideal for use in clinical settings such as operating rooms (ORs), emergency rooms (ERs), and intensive care units (ICUs). Similarly, various international players have launched more such hemodynamic monitoring systems. For instance, in March 2018, Canon Medical Systems Corporation (Japan) acquired a Netherlands-based company named Fysicon B.V. In September 2017, Fysicon B.V. received FDA’s Section 510(k) clearance for its QMAPP Hemodynamic Monitoring systems designed for monitoring the cardiac conditions of patients in cardiac catheterization labs. Further, in April 2016, Siemens Healthineers (Siemens AG) launched its revamped version of Sensis Vibe. The system was launched at the American College of Cardiology’s 65th Annual Scientific Session (ACC.16), held during April 2–4, 2016, in Chicago, Illinois, US. The system enables catheterization lab professionals to manage data proficiently, and it also assists in streaming down the documentation and reporting in the interventional treatments.
In 2019, the invasive hemodynamic monitoring system segment accounted for the largest market share in US hemodynamic monitoring system market by type. However, it is estimated that noninvasive hemodynamic monitoring system is likely to grow at a faster pace over the forecast period. By product segment disposable segment held largest share of the market and monitors segment is expected to grow at a faster pace. Whereas, by end user, hospitals segment held largest share in the market and is also estimated to grow at a faster pace during the forecast period.
US Hemodynamic Monitoring System Market Revenue and Forecast to 2027 (US$ Mn)
Get more information on this report :
US HEMODYNAMIC MONITORING SYSTEM – MARKET SEGMENTATION
By Type
- Noninvasive Hemodynamic Monitoring System
- NICaS
- Others
- Minimally Invasive Hemodynamic Monitoring System
- Invasive Hemodynamic Monitoring System
By Product
- Monitors
- Disposables
By End User
- Hospitals
- Cath Labs
- Home Care
- Ambulatory Care Centers
Company Profiles
- General Electric Company
- LIDCO
- Pulsion Medical Systems SE (Getinge)
- Koninklijke Philips N.V
- ICU Medical, Inc.
- Cheetah Medical (Baxter International)
- Deltex Medical
- Schwarzer Cardiotek
- Edwards Lifesciences Corporation
- Osypka Medical GmBH
1. Introduction
1.1 Study Scope
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 US Hemodynamic Monitoring System Market – By Type
1.3.2 US Hemodynamic Monitoring System Market – By Product
1.3.3 US Hemodynamic Monitoring System Market – By End User
2. Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. US Hemodynamic Monitoring System Market Landscape
4.1 Market Overview
4.2 PEST Analysis
4.2.1 US: PEST Analysis
4.3 Expert Opinion
5. US Hemodynamic Monitoring System Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Increasing product developments and approvals
5.1.2 Rising cardiovascular disease prevalence
5.1.3 Growing geriatric population
5.2 Market Restraints
5.2.1 Risks associated with invasive hemodynamic monitoring systems
5.3 Market Opportunities
5.3.1 Changing medical and financial conditions in developing nations
5.4 Future Trends
5.4.1 Increasing trend for noninvasive devices
5.5 Impact Analysis of Drivers and Restraints
6. Hemodynamic Monitoring System – US Market Analysis
6.1 US Hemodynamic Monitoring System Market Overview
6.2 Market Positioning of Key Players
7. US Hemodynamic Monitoring System Market Analysis – By Type
7.1 Overview
7.2 US Hemodynamic Monitoring System Market, By Type (2019 and 2027)
7.3 Noninvasive Hemodynamic Monitoring System
7.3.1 Overview
7.3.2 Noninvasive Hemodynamic Monitoring System: US Hemodynamic Monitoring System Market – Revenue, and Forecast to 2027 (US$ Million)
7.3.3 NICaS
7.3.3.1 Overview
7.3.3.2 NICaS: US Hemodynamic Monitoring System Market – Revenue, and Forecast to 2027 (US$ Million)
7.3.4 Others
7.3.4.1 Overview
7.3.4.2 Others: US Hemodynamic Monitoring System Market – Revenue, and Forecast to 2027 (US$ Million)
7.4 Minimally Invasive Hemodynamic Monitoring System
7.4.1 Overview
7.4.2 Minimally Invasive Hemodynamic Monitoring System: US Hemodynamic Monitoring System Market – Revenue, and Forecast to 2027 (US$ Million)
7.5 Invasive Hemodynamic Monitoring System
7.5.1 Overview
7.5.2 Invasive Hemodynamic Monitoring System: US Hemodynamic Monitoring System Market – Revenue, and Forecast to 2027 (US$ Million)
8. US Hemodynamic Monitoring System Market Analysis – By Product
8.1 Overview
8.2 US Hemodynamic Monitoring System Market, By Product (2019 and 2027)
8.3 Monitors
8.3.1 Overview
8.3.2 Monitors: US Hemodynamic Monitoring System Market – Revenue, and Forecast to 2027 (US$ Million)
8.4 Disposables
8.4.1 Overview
8.4.2 Disposables: US Hemodynamic Monitoring System Market – Revenue, and Forecast to 2027 (US$ Million)
9. US Hemodynamic Monitoring System Market Analysis – By End User
9.1 Overview
9.2 US Hemodynamic Monitoring System Market, By End User (2019 and 2027)
9.3 Hospitals
9.3.1 Overview
9.3.2 Hospitals: US Hemodynamic Monitoring System Market – Revenue, and Forecast to 2027 (US$ Million)
9.4 Cath Labs
9.4.1 Overview
9.4.2 Cath Labs: US Hemodynamic Monitoring System Market – Revenue, and Forecast to 2027 (US$ Million)
9.5 Home Care
9.5.1 Overview
9.5.2 Home Care: US Hemodynamic Monitoring System Market – Revenue, and Forecast to 2027 (US$ Million)
9.6 Ambulatory Care Centers
9.6.1 Overview
9.6.2 Ambulatory Care Centers: US Hemodynamic Monitoring System Market – Revenue, and Forecast to 2027 (US$ Million)
10. US Hemodynamic Monitoring Systems Market –Industry Landscape
10.1 Overview
11. COMPANY PROFILES
11.1 Koninklijke Philips N.V.
11.1.1 Key Facts
11.1.2 Business Description
11.1.3 Products and Services
11.1.4 Financial Overview
11.1.5 SWOT Analysis
11.1.6 Key Developments
11.2 Osypka Medical GmbH
11.2.1 Key Facts
11.2.2 Business Description
11.2.3 Products and Services
11.2.4 Financial Overview
11.2.5 SWOT Analysis
11.2.6 Key Developments
11.3 General Electric Company
11.3.1 Key Facts
11.3.2 Business Description
11.3.3 Products and Services
11.3.4 Financial Overview
11.3.5 SWOT Analysis
11.3.6 Key Developments
11.4 Edwards Lifesciences Corporation
11.4.1 Key Facts
11.4.2 Business Description
11.4.3 Products and Services
11.4.4 Financial Overview
11.4.5 SWOT Analysis
11.4.6 Key Developments
11.5 Schwarzer Cardiotek
11.5.1 Key Facts
11.5.2 Business Description
11.5.3 Products and Services
11.5.4 Financial Overview
11.5.5 SWOT Analysis
11.5.6 Key Developments
11.6 LiDCO
11.6.1 Key Facts
11.6.2 Business Description
11.6.3 Products and Services
11.6.4 Financial Overview
11.6.5 SWOT Analysis
11.6.6 Key Developments
11.7 Getinge Group
11.7.1 Key Facts
11.7.2 Business Description
11.7.3 Products and Services
11.7.4 Financial Overview
11.7.5 SWOT Analysis
11.7.6 Key Developments
11.8 DELTEX MEDICAL
11.8.1 Key Facts
11.8.2 Business Description
11.8.3 Products and Services
11.8.4 Financial Overview
11.8.5 SWOT Analysis
11.8.6 Key Developments
11.9 ICU MEDICAL INC.
11.9.1 Key Facts
11.9.2 Business Description
11.9.3 Products and Services
11.9.4 Financial Overview
11.9.5 SWOT Analysis
11.9.6 Key Developments
11.10 Cheetah Medical (Baxter International)
11.10.1 Key Facts
11.10.2 Business Description
11.10.3 Products and Services
11.10.4 Financial Overview
11.10.5 SWOT Analysis
11.10.6 Key Developments
12. Appendix
12.1 About The Insight Partners
12.2 Word Index
LIST OF TABLES
Table 1. List of Abbreviation
LIST OF FIGURES
Figure 1. US Hemodynamic Monitoring System Market Segmentation
Figure 2. US Hemodynamic Monitoring System Market Overview
Figure 3. Invasive Hemodynamic Monitoring System is Expected to Show Remarkable Growth During Forecast Period
Figure 4. Monitors is Expected to Have Fastest Growth During Forecast Period
Figure 5. US: PEST Analysis
Figure 6. Expert Opinion
Figure 7. US Hemodynamic Monitoring System Market – Impact Analysis of Drivers and Restraints
Figure 8. Overview of US Hemodynamic Monitoring System Market
Figure 9. Market Positioning Of Key Players In US Hemodynamic Monitoring System Market
Figure 10. US Hemodynamic Monitoring System Market Revenue Share, by Type (2019 and 2027)
Figure 11. Noninvasive Hemodynamic Monitoring System: US Hemodynamic Monitoring System Market – Revenue, and Forecast to 2027 (US$ Million)
Figure 12. NICaS: US Hemodynamic Monitoring System Market – Revenue, and Forecast to 2027 (US$ Million)
Figure 13. Others: US Hemodynamic Monitoring System Market – Revenue, and Forecast to 2027 (US$ Million)
Figure 14. Minimally Invasive Hemodynamic Monitoring System: US Hemodynamic Monitoring System Market – Revenue, and Forecast to 2027 (US$ Million)
Figure 15. Invasive Hemodynamic Monitoring System: US Hemodynamic Monitoring System Market – Revenue, and Forecast to 2027 (US$ Million)
Figure 16. US Hemodynamic Monitoring System Market Revenue Share, by Product (2019 and 2027)
Figure 17. Monitors: US Hemodynamic Monitoring System Market – Revenue, and Forecast to 2027 (US$ Million)
Figure 18. Disposables: US Hemodynamic Monitoring System Market – Revenue, and Forecast to 2027 (US$ Million)
Figure 19. US Hemodynamic Monitoring System Market Revenue Share, by End User (2019 and 2027)
Figure 20. Hospitals: US Hemodynamic Monitoring System Market – Revenue, and Forecast to 2027 (US$ Million)
Figure 21. Cath Labs: US Hemodynamic Monitoring System Market – Revenue, and Forecast to 2027 (US$ Million)
Figure 22. Home Care: US Hemodynamic Monitoring System Market – Revenue, and Forecast to 2027 (US$ Million)
Figure 23. Ambulatory Care Centers: US Hemodynamic Monitoring System Market – Revenue, and Forecast to 2027 (US$ Million)
The List of Companies - US Hemodynamic Monitoring System Market
- General Electric Company
- LIDCO
- Pulsion Medical Systems SE (Getinge)
- Koninklijke Philips N.V
- ICU Medical, Inc.
- Cheetah Medical (Baxter International)
- Deltex Medical
- Schwarzer Cardiotek
- Edwards Lifesciences Corporation
- Osypka Medical GmBH
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the US hemodynamic monitoring system market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the US hemodynamic monitoring system market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth regional market trends and outlook coupled with the factors driving the market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.